Search Results

There are 4566 results for: content related to: Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro

  1. You have free access to this content
    Role of the PD-1 Pathway in the Immune Response

    American Journal of Transplantation

    Volume 12, Issue 10, October 2012, Pages: 2575–2587, L. V. Riella, A. M. Paterson, A. H. Sharpe and A. Chandraker

    Version of Record online : 17 AUG 2012, DOI: 10.1111/j.1600-6143.2012.04224.x

  2. You have full text access to this OnlineOpen article
    PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy

    EMBO Molecular Medicine

    Volume 9, Issue 2, February 2017, Pages: 167–180, Abul Azad, Su Yin Lim, Zenobia D'Costa, Keaton Jones, Angela Diana, Owen J Sansom, Philipp Kruger, Stanley Liu, W Gillies McKenna, Omer Dushek, Ruth J Muschel and Emmanouil Fokas

    Version of Record online : 8 DEC 2016, DOI: 10.15252/emmm.201606674

  3. PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies

    Tissue Antigens

    Volume 69, Issue 1, January 2007, Pages: 19–27, J. Sun, K. Xu, C Wu, Y Wang, Y Hu, Y Zhu, Y Chen, Q Shi, G Yu and X Zhang

    Version of Record online : 6 DEC 2006, DOI: 10.1111/j.1399-0039.2006.00701.x

  4. Recent Insight into the Role of the PD-1/PD-L1 Pathway in Feto-Maternal Tolerance and Pregnancy

    American Journal of Reproductive Immunology

    Volume 74, Issue 3, September 2015, Pages: 201–208, Yong-Hong Zhang, Mei Tian, Mao-Xing Tang, Zhao-Zhao Liu and Ai-Hua Liao

    Version of Record online : 31 JAN 2015, DOI: 10.1111/aji.12365

  5. You have free access to this content
    Overall survival and PD-L1 expression in metastasized malignant melanoma


    Volume 117, Issue 10, 15 May 2011, Pages: 2192–2201, Jules Gadiot, Anna I. Hooijkaas, Andrew D. M. Kaiser, Harm van Tinteren, Hester van Boven and Christian Blank

    Version of Record online : 29 NOV 2010, DOI: 10.1002/cncr.25747

  6. The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer

    Pediatric Blood & Cancer

    Volume 62, Issue 2, February 2015, Pages: 190–197, Laura S. van Dam, Verena M. de Zwart and Friederike A.G. Meyer-Wentrup

    Version of Record online : 18 OCT 2014, DOI: 10.1002/pbc.25284

  7. You have full text access to this OnlineOpen article
    Anti-PD-L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma

    Cancer Science

    Volume 107, Issue 12, December 2016, Pages: 1736–1744, Yukiyoshi Hirayama, Min Gi, Shotaro Yamano, Hirokazu Tachibana, Takahiro Okuno, Satoshi Tamada, Tatsuya Nakatani and Hideki Wanibuchi

    Version of Record online : 13 DEC 2016, DOI: 10.1111/cas.13099

  8. You have free access to this content
    Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens

    European Journal of Immunology

    Volume 41, Issue 2, February 2011, Pages: 345–355, Masashi Iwasaki, Yoshimasa Tanaka, Hirohito Kobayashi, Kaoru Murata-Hirai, Hideto Miyabe, Tomoharu Sugie, Masakazu Toi and Nagahiro Minato

    Version of Record online : 11 JAN 2011, DOI: 10.1002/eji.201040959

  9. You have free access to this content
    Role of PD-L1 and PD-L2 in allergic diseases and asthma


    Volume 66, Issue 2, February 2011, Pages: 155–162, A. K. Singh, P. Stock and O. Akbari

    Version of Record online : 17 AUG 2010, DOI: 10.1111/j.1398-9995.2010.02458.x

  10. You have free access to this content
    Checkpoint blocking antibodies in cancer immunotherapy

    FEBS Letters

    Volume 588, Issue 2, January 21, 2014, Pages: 368–376, Chrisann Kyi and Michael A. Postow

    Version of Record online : 23 OCT 2013, DOI: 10.1016/j.febslet.2013.10.015

  11. You have free access to this content
    Japanese encephalitis virus expands regulatory T cells by increasing the expression of PD-L1 on dendritic cells

    European Journal of Immunology

    Volume 44, Issue 5, May 2014, Pages: 1363–1374, Nimesh Gupta, Pushpa Hegde, Maxime Lecerf, Minu Nain, Manpreet Kaur, Manjula Kalia, Sudhanshu Vrati, Jagadeesh Bayry, Sébastien Lacroix-Desmazes and Srini V. Kaveri

    Version of Record online : 24 MAR 2014, DOI: 10.1002/eji.201343701

  12. You have free access to this content
    Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma


    Volume 116, Issue 7, 1 April 2010, Pages: 1757–1766, Ryosuke Hino, Kenji Kabashima, Yu Kato, Hiroaki Yagi, Motonobu Nakamura, Tasuku Honjo, Taku Okazaki and Yoshiki Tokura

    Version of Record online : 8 FEB 2010, DOI: 10.1002/cncr.24899

  13. You have free access to this content
    Abstracts of ICI 2016 International Congress of Immunology, 21–26 August 2016, Melbourne, Australia

    European Journal of Immunology

    Volume 46, Issue S1, August 2016, Pages: 1–1274,

    Version of Record online : 19 AUG 2016, DOI: 10.1002/eji.201670200

  14. You have free access to this content
    Differential control of CD4+ T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma

    European Journal of Immunology

    Volume 45, Issue 4, April 2015, Pages: 1019–1029, Jaclyn W. McAlees, Stephane Lajoie, Krista Dienger, Alyssa A. Sproles, Phoebe K. Richgels, Yanfen Yang, Marat Khodoun, Miyuki Azuma, Hideo Yagita, Patricia C. Fulkerson, Marsha Wills-Karp and Ian P. Lewkowich

    Version of Record online : 26 FEB 2015, DOI: 10.1002/eji.201444778

  15. PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials

    Pigment Cell & Melanoma Research

    Volume 28, Issue 3, May 2015, Pages: 245–253, Jason Madore, Ricardo E. Vilain, Alexander M. Menzies, Hojabr Kakavand, James S. Wilmott, Jessica Hyman, Jennifer H. Yearley, Richard F. Kefford, John F. Thompson, Georgina V. Long, Peter Hersey and Richard A. Scolyer

    Version of Record online : 22 DEC 2014, DOI: 10.1111/pcmr.12340

  16. You have full text access to this OnlineOpen article
    Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy

    Cancer Science

    Volume 106, Issue 8, August 2015, Pages: 945–950, Keishi Adachi and Koji Tamada

    Version of Record online : 2 JUL 2015, DOI: 10.1111/cas.12695

  17. Costimulatory and coinhibitory receptors in anti-tumor immunity

    Immunological Reviews

    Volume 229, Issue 1, May 2009, Pages: 126–144, Gregory Driessens, Justin Kline and Thomas F. Gajewski

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1600-065X.2009.00771.x

  18. Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas


    Volume 68, Issue 7, June 2016, Pages: 1079–1089, Dohee Kwon, Sehui Kim, Pil-Jong Kim, Heounjeong Go, Soo Jeong Nam, Jin Ho Paik, Young A Kim, Tae Min Kim, Dae Seog Heo, Chul Woo Kim and Yoon Kyung Jeon

    Version of Record online : 1 DEC 2015, DOI: 10.1111/his.12882

  19. You have free access to this content
    PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata


    Volume 109, Issue 8, 15 April 2007, Pages: 1499–1505, Brant A. Inman, Thomas J. Sebo, Xavier Frigola, Haidong Dong, Eric J. Bergstralh, Igor Frank, Yves Fradet, Louis Lacombe and Eugene D. Kwon

    Version of Record online : 5 MAR 2007, DOI: 10.1002/cncr.22588

  20. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis


    Volume 20, Issue 12, December 2015, Pages: 892–898, Joshua D Ooi, Ming Li, Katerina Kourkoutzelos, Hideo Yagita, Miyuki Azuma, Stephen R Holdsworth and A Richard Kitching

    Version of Record online : 28 OCT 2015, DOI: 10.1111/nep.12532